## CTAS: Cintas Corporation - XLI: Industrials

### Executive Summary

No thesis match: PEG 3.55 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($181.31)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. The Bull Case For Cintas (CTAS) Could Change Following New Employment And Margin Concerns – Learn Why**
- Source: Simply Wall Street | 20251217T110817 | Somewhat-Bearish | Relevance: 100%
- Cintas Corporation's stock has faced pressure due to concerns over employment trends, pricing, and cost, despite better-than-expected quarterly results. The company's historic strength in recurring revenue and free cash flow is being weighed against a potentially softer employment market and margin pressures. Investors are now focused on how these factors will impact Cintas's growth drivers and investment narrative moving forward.

**2. Cintas stock split: what’s next for CTAS shares?**
- Source: Capital.com | 20251217T110801 | Somewhat-Bullish | Relevance: 100%
- Cintas Corporation (CTAS) completed a 4-for-1 stock split in September 2024 to enhance share accessibility for investors and employees, following a period of strong financial performance and share price appreciation. As of December 2025, no further splits are anticipated, with the company's FY2025 results showing robust revenue and EPS growth. Cintas has a history of multiple stock splits, with a single share from 1987 now equating to approximately 72 shares.

**3. Cintas (CTAS) Q4 Earnings: What To Expect**
- Source: Finviz | 20251217T100753 | Somewhat-Bullish | Relevance: 100%
- Cintas (CTAS) is set to report its Q4 earnings on Thursday before the market opens, with analysts expecting revenue to grow 7.8% year over year to $2.76 billion and adjusted earnings of $1.20 per share. The company has a strong record of exceeding revenue estimates and enters earnings with positive investor sentiment in its segment. Cintas is the first among its peers to report, making its performance a key indicator for the business services & supplies sector.

**4. Cintas Q4 2025 Earnings Preview: Revenue & EPS Forecast for Dec 18 - News and Statistics**
- Source: IndexBox | 20251217T090739 | Somewhat-Bullish | Relevance: 100%
- Cintas (CTAS) is projected to report its fiscal fourth-quarter earnings before market open on December 18, 2025. Analysts expect revenue of $2.76 billion, a 7.8% increase year-over-year, and adjusted earnings of $1.20 per share. Despite missing analyst estimates for full-year guidance last quarter, the company has consistently beaten revenue estimates in the past two years.

**5. Has the Market Run Too Far Ahead of Cintas After Its Strong Multi Year Rally?**
- Source: Simply Wall Street | 20251216T000759 | Somewhat-Bearish | Relevance: 100%
- Cintas (NasdaqGS:CTAS) has seen mixed performance recently, with gains over the last week and year-to-date, but a decline over the past year despite strong multi-year growth. Simply Wall St's analysis suggests the stock is currently overvalued, with a Discounted Cash Flow (DCF) implying it's 14.5% overvalued and its Price-to-Earnings (PE) ratio of 40.85x exceeding its Fair Ratio of 32.51x. The article encourages investors to use "Narratives" to apply their own market views to Cintas's valuation.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | Morgan Stanley | $210 | $220 | -5% |
| 2025-11-25 | Wells Fargo | $185 | $218 | -15% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | Morgan Stanley | main | Equal-Weight |
| 2025-11-25 | Wells Fargo | main | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 7 ($0.00M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 29.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 3 |

**Top Holders:**
- Vanguard Group Inc: 9.7% (+1.5%)
- Blackrock Inc.: 7.2% (+2.1%)
- State Street Corpora: 3.8% (-0.1%)
- Geode Capital Manage: 2.3% (+0.1%)
- FMR, LLC: 2.2% (-10.1%)

### Key Risks

1. Valuation stretched: PEG 3.5x requires aggressive growth execution.
2. Long-term trend broken: trading 8.9% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Momentum building: MRS_10 improving +1.9% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 3.55 signals overvaluation risk, limited margin of safety. Forward P/E 35.1x stretched relative to 10% growth. Quality metrics strong (ROE 42%, ROA 16%, margin 18%). Balance sheet: strong liquidity (2.2x). Analyst sentiment negative (2 target cuts vs 0 raises). Institutional flow bullish (6 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $75.5B |
| Beta | 0.96 |
| 52W Range | $180.39 - $229.24 |
| Short Interest | 2.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.55 |
| Forward P/E | 35.1 |
| Current P/E | 38.8 |
| YoY Growth | 10.5% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from 1.6% to 3.5% (+1.9% in 5 days), confirming momentum buildup. Currently in lower STRENGTH zone (3.0-6.0%), cross-sectional ranking at 65th percentile. MRS_5 at 1.6% confirms short-term momentum alignment. Below SMA200 (0.91x), long-term trend not supportive. MACD histogram positive (0.63), confirming momentum. RSI neutral at 53. OFD pattern: +DUN (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 3.51% (CS: 66) | Strong |
| RSI_14 | 52.6 | Neutral |
| MACD Histogram | 0.63 | Bullish |
| vs SMA20 | 1.011x | Above |
| vs SMA50 | 1.003x | Above |
| vs SMA200 | 0.911x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $187.37
- **Stop Loss:** $181.31 (3.2% risk)
- **Target:** $193.43 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 178
- **Position Value:** $33,351.86
- **Portfolio %:** 33.35%
- **Risk Dollars:** $1,080.00
- **Risk Per Trade:** 1.08%
- **Modifiers:** L1 90% | L2 120% | Combined 1.08x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | RISK_OFF (HIGH) | 0.90x |
| L2 Sector | TREND (Zone A) | 1.20x |

*RISK_OFF regime with deteriorating conditions. VIX rising to 17.6 (+11.7% over 5 days) signals increasing anxiety, while narrow breadth at 52.6% indicates selective participation. AI infrastructure cost concerns are pressuring tech leadership, creating sector rotation challenges in a late-cycle environment.*

### Earnings

**Next:** 2025-12-18 (Est: $1.20)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.20 | $1.20 | +0.3% |
| 2025Q2 | $1.07 | $1.09 | +1.9% |
| 2025Q1 | $1.06 | $1.13 | +7.1% |
| 2024Q4 | $1.02 | $1.09 | +7.1% |

---
*RULE-based L3 | 2026-01-07 01:40 | MRS_10*